Potential of siRNA-Bearing Subtilosomes in the Treatment of Diethylnitrosamine-Induced Hepatocellular Carcinoma

Therapeutics, based on small interfering RNA (siRNA), have demonstrated tremendous potential for treating cancer. However, issues such as non-specific targeting, premature degradation, and the intrinsic toxicity of the siRNA, have to be solved before they are ready for use in translational medicines...

Descripción completa

Detalles Bibliográficos
Autores principales: Jamal, Fauzia, Ahmed, Ghufran, Farazuddin, Mohammad, Altaf, Ishrat, Farheen, Saba, Zia, Qamar, Azhar, Asim, Ahmad, Hira, Khan, Aijaz Ahmed, Somavarapu, Satyanarayana, Agrawal, Anshu, Owais, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004640/
https://www.ncbi.nlm.nih.gov/pubmed/36903437
http://dx.doi.org/10.3390/molecules28052191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004640/
https://www.ncbi.nlm.nih.gov/pubmed/36903437
http://dx.doi.org/10.3390/molecules28052191

Ejemplares similares